title: Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (IV): phenanthroindolizidine alkaloids from Tylophora tanakae leaves.
abstract: Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature peripheral T lymphocytes caused by human T-cell lymphotropic virus type 1 (HTLV-1). There are an estimated 5 million to 20 million HTLV-1-infected individuals worldwide; their lifetime risk of developing ATL is 3-5 %, and high HTLV-1 proviral loads have been shown to be an independent risk factor. Although conventional chemotherapeutic regimens used against other malignant lymphomas have been administered to ATL patients, the prognosis is often poor. In previous studies, we screened 459 extracts from 344 plants to isolate components exhibiting antiproliferative activity against HTLV-1-infected T-cell lines (MT-1 and MT-2). In our continuing search for potential anti-HTLV-1 natural products, 15 extracts of Asclepiadaceae plants were further tested against MT-1 and MT-2 cells. The MeOH extract of aerial parts of Tylophora tanakae showed antiproliferative activity. Activity-guided fractionation resulted in the isolation of 6 phenanthroindolizidine alkaloids (including a new compound), and we examined their antiproliferative activity against MT-1 and MT-2 cells. The EC50 value of some of the alkaloids was in the low nanomolar range, comparable to that of the clinically used antineoplastic drug doxorubicin. Structure-activity relationship analyses suggested that a 14β-hydroxy moiety is essential for activity against HTLV-1-infected T cells. In contrast, the presence of a 2-methoxy moiety, a 7-methoxy moiety, or an N-oxide moiety appears to reduce the potency of the antiproliferative activity against HTLV-1-infected T cells.
authors.affiliation: Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nakano
authors.forename: Kenji
authors.initials: K
authors.lastname: Ishitsuka
authors.forename: Mizuki
authors.initials: M
authors.lastname: Ikeda
authors.forename: Ryota
authors.initials: R
authors.lastname: Tsuchihashi
authors.forename: Masafumi
authors.initials: M
authors.lastname: Okawa
authors.forename: Hikaru
authors.initials: H
authors.lastname: Okabe
authors.forename: Kazuo
authors.initials: K
authors.lastname: Tamura
authors.forename: Junei
authors.initials: J
authors.lastname: Kinjo
mesh_terms: D000470:Alkaloids / Q000302:isolation & purification / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D015490:HTLV-I Infections / Q000188:drug therapy; D006801:Humans; D007212:Indolizines / Q000302:isolation & purification / Q000494:pharmacology; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000821:virology; D010618:Phenanthrolines / Q000302:isolation & purification / Q000494:pharmacology; D018515:Plant Leaves / Q000737:chemistry; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000187:drug effects; D031110:Tylophora / Q000737:chemistry*
chemical_list: D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; D007212:Indolizines; D010618:Phenanthrolines; C521640:phenanthroindolizidine
references.citation: Bioorg Med Chem Lett. 2011 Oct 1;21(19):5978-81
references.pmid: 21865039
references.citation: J Nat Prod. 2002 Sep;65(9):1299-302
references.pmid: 12350151
references.citation: J Clin Oncol. 2010 Mar 20;28(9):1591-8
references.pmid: 20177026
references.citation: Chem Pharm Bull (Tokyo). 1998 May;46(5):767-9
references.pmid: 9621409
references.citation: J Nat Med. 2011 Jul;65(3-4):559-67
references.pmid: 21573698
references.citation: J Nat Med. 2013 Apr;67(2):415-20
references.pmid: 22961603
references.citation: Toxicol In Vitro. 2000 Feb;14(1):53-9
references.pmid: 10699361
references.citation: Eur J Haematol. 2008 Mar;80(3):185-96
references.pmid: 18081707